Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Richard B. Lipton, Robert Croop, David Stock, Jennifer Madonia, Micaela Forshaw, Meghan Lovegren, Linda Mosher, Vladimir Coric, Peter J. Goadsby
Topics & Concepts
TolerabilityMedicineMigrainePlaceboNauseaNasal sprayRandomized controlled trialClinical trialAdverse effectInternal medicinePhysical therapyAnesthesiaNasal administrationPharmacologyAlternative medicinePathologyMigraine and Headache StudiesRespiratory and Cough-Related ResearchNausea and vomiting management